Annabel Maruani
3
Documents
Identifiants chercheurs
annabel-maruani- ResearcherId : L-9017-2015
- IdRef : 088646270
-
0000-0003-3734-810X
- ResearcherId : http://www.researcherid.com/rid/L-9017-2015
Présentation
Publications
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 1
- 2
- 1
- 1
- 1
- 1
Sirolimus (Rapamycin) for Slow-Flow Malformations in ChildrenJAMA Dermatology, inPress, ⟨10.1001/jamadermatol.2021.3459⟩
Article dans une revue
hal-03408026v1
|
|
|
|
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.Trials, 2019, 20 (1), ⟨10.1186/s13063-019-3767-8⟩
Article dans une revue
hal-02622848v1
|
|
|
Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase designTrials, 2018, 19 (1), pp.340. ⟨10.1186/s13063-018-2725-1⟩
Article dans une revue
hal-01913363v1
|